If you have been eyeing DEXUS stock lately, you are not alone. Many investors are taking a closer look after a pretty interesting stretch in the numbers. Just in the past year, DEXUS has seen a gain of 3.3%, and over the last five years, the stock has delivered a solid 7.8%. Those are steady figures, but what stands out is the stock’s bounce back this year, up 9.3% so far. This hints at renewed optimism around its future and perhaps changing views on risk in the sector. That said, short-term swings have been a bit more subdued, with only a mild 0.6% move in the past month and a slight dip of 1.4% this last week. While that could simply be the market finding its footing, it often points to investors waiting for a clearer story or the next wave of catalysts. Recent market trends for real estate investment trusts suggest that sentiment might be shifting toward growth, and DEXUS is certainly in the mix. But is now the right moment to dive in, hold, or stay on the sidelines? That is where valuation gets interesting. On a six-point scoring system that checks for undervaluation, DEXUS scores a 3, meaning it is undervalued on half of the metrics that matter. Coming up, we will break down exactly which approaches light up that scorecard and which fall short. For those wanting a deeper dive, we will wrap up with an even sharper way to make sense of what DEXUS is truly worth. Why DEXUS is lagging behind its peers Approach 1: DEXUS Discounted Cash Flow (DCF) Analysis The Discounted Cash Flow (DCF) model attempts to estimate a company's value by projecting its expected adjusted funds from operations into the future and then discounting those cash flows back to today's value. For DEXUS, this approach relies on forecasting its Free Cash Flow (FCF), using a two-stage method that factors in both analyst estimates and extended projections. DEXUS currently generates A$483.9 million in free cash flow. Analyst projections expect this to rise gradually, reaching approximately A$537.8 million by June 2030. While analyst forecasts are available for the next five years, estimates beyond that period are extrapolated by Simply Wall St. Over the next decade, annual Free Cash Flow continues a modestly upward trajectory, reflecting stable operations and incremental growth within the Office REIT sector. Based on these cash flows, the DCF model calculates an intrinsic value for DEXUS shares at A$10.50. This represents a 30.6% discount to the current trading price, indicating that the stock is noticeably undervalued according to this methodology. Story Continues Result: UNDERVALUED Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for DEXUS.DXS Discounted Cash Flow as at Sep 2025 Our Discounted Cash Flow (DCF) analysis suggests DEXUS is undervalued by 30.6%. Track this in your watchlist or portfolio, or discover more undervalued stocks. Approach 2: DEXUS Price vs Earnings The Price-to-Earnings (PE) ratio is a popular tool for valuing profitable companies like DEXUS because it tells us how much investors are willing to pay for each dollar of earnings. A lower PE may indicate a bargain, while a higher PE can signal expectations of faster growth or lower risk. However, what counts as a “fair” PE ratio is shaped by many factors, including growth prospects, profitability, and the risks tied to the business or industry outlook. Currently, DEXUS trades at a PE ratio of 57.4x. Compared to the Office REITs industry average of 23.1x and typical peer companies at 86.1x, DEXUS sits above its industry average but below similar-sized rivals. These differences often reflect nuances in business models, financial stability, and the unique outlook for each company. Simply Wall St’s proprietary Fair Ratio goes a step further. Instead of only comparing DEXUS to industry or peer averages, it calculates a custom benchmark (23.1x) tailored to DEXUS, based on its earnings growth, business risks, margins, and market size. This makes the Fair Ratio a more holistic and useful yardstick for long-term investors. It provides more context around what DEXUS should be worth in today’s market rather than relying on a one-size-fits-all average. When comparing DEXUS’s current PE (57.4x) to its Fair Ratio (23.1x), the stock appears overvalued on this metric. Result: OVERVALUEDASX:DXS PE Ratio as at Sep 2025 PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover companies where insiders are betting big on explosive growth. Upgrade Your Decision Making: Choose your DEXUS Narrative Earlier we mentioned that there's an even better way to understand valuation, so let's introduce you to Narratives. A Narrative is simply your own story for a company like DEXUS. You outline what you think will happen to its revenue, earnings, and margins in the future, and from this, a fair value is estimated based on your assumptions. Narratives connect the dots between the company’s unique outlook, the numbers behind it, and whether the stock’s current price is justified. This approach lets you frame your investment decision with a personal perspective, not just rigid formulas. Narratives are easy to use and openly available through the Simply Wall St Community page, where millions of investors share and learn from each other's perspectives. What makes Narratives powerful is that they help you map out exactly when you would consider buying or selling. You compare your calculated fair value with the real-time share price to see if the opportunity matches your view. They also automatically refresh every time new financial results or news is released, so your outlook stays current. For example, one DEXUS investor expects strong logistics trends to drive a price target of A$9.6 per share, while another is more cautious and sees potential headwinds, setting their target at just A$7.25. Do you think there's more to the story for DEXUS? Create your own Narrative to let the Community know!ASX:DXS Community Fair Values as at Sep 2025 This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include DXS.AX. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
Assessing Dexus After 9.3% Rally and Renewed Sector Optimism in 2025
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...